BARCLAYS PLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 72 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$19
-99.0%
21,271
-98.7%
0.00%
-100.0%
Q4 2022$1,907
-100.0%
1,615,447
+206.7%
0.00%
-75.0%
Q3 2022$3,966,000
+19.4%
526,767
-0.1%
0.00%
+100.0%
Q2 2022$3,321,000
-20.8%
527,056
+4.3%
0.00%
-33.3%
Q1 2022$4,193,000
+937.9%
505,197
+550.1%
0.00%
Q4 2021$404,000
+364.4%
77,716
+493.8%
0.00%
Q3 2021$87,000
+24.3%
13,089
+57.6%
0.00%
Q2 2021$70,000
-70.2%
8,307
-68.7%
0.00%
Q1 2021$235,000
-71.1%
26,566
-59.8%
0.00%
Q4 2020$814,000
+15.6%
66,124
-23.6%
0.00%
Q3 2020$704,000
+33.6%
86,535
+57.4%
0.00%
Q2 2020$527,000
+328.5%
54,963
+207.3%
0.00%
Q1 2020$123,000
-67.2%
17,884
-29.1%
0.00%
Q4 2019$375,000
+164.1%
25,220
+81.0%
0.00%
Q3 2019$142,000
-24.1%
13,934
-20.9%
0.00%
Q2 2019$187,000
-81.6%
17,606
-75.8%
0.00%
-100.0%
Q1 2019$1,016,000
+15.3%
72,697
-16.1%
0.00%0.0%
Q4 2018$881,00086,646
+2166050.0%
0.00%
Q3 2018$040.0%0.00%
Q2 2018$040.0%0.00%
Q1 2018$0
-100.0%
4
-99.9%
0.00%
Q4 2017$78,0005,604
+140000.0%
0.00%
Q3 2017$0
-100.0%
4
-99.9%
0.00%
Q2 2017$56,000
+700.0%
7,104
+1033.0%
0.00%
Q1 2017$7,000627
+15575.0%
0.00%
Q4 2016$04
-86.7%
0.00%
Q3 2016$030
+650.0%
0.00%
Q2 2016$040.0%0.00%
Q1 2016$040.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders